Advanced search
Publication Cover
Drug Delivery Volume 27, 2020 - Issue 1
Submit an article Journal homepage
1,908
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Developing protein arginine methyltransferase 1 (PRMT1) inhibitor TC-E-5003 as an antitumor drug using INEI drug delivery systems

Pengcheng Zhanga College of Life Sciences, Zhejiang University, Hangzhou, China
,
He Taob Institute of Hygiene, Zhejiang Academy of Medical Science, China
,
Liyang Yua College of Life Sciences, Zhejiang University, Hangzhou, China
,
Lixiao Zhoua College of Life Sciences, Zhejiang University, Hangzhou, China
&
Chenggang Zhua College of Life Sciences, Zhejiang University, Hangzhou, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5595-9444
ORCID Icon
Pages 491-501 | Received 15 Jan 2020, Accepted 17 Mar 2020, Published online: 26 Mar 2020

References

  • Bissinger E, Heinke R, Spannhoff A, et al. (2011). Bioorganic & medicinal chemistry acyl derivatives of p -aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1. Bioorgan Med Chem 19:3717–31.
  • Branscombe TL, Frankel A, Lee JH, et al. (2001). PRMT5 (Janus Kinase-binding Protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins. J Biol Chem 276:32971–6.
  • Bray F, Ferlay J, Soerjomataram I, et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 68:394–424.
  • Brudno Y, Mooney DJ. (2015). On-demand drug delivery from local depots. J Controlled Release 219:8–17.
  • Chakravarty R, Hong H, Cai W. (2015). Image-guided drug delivery with single-photon emission computed tomography: a review of literature. Cur Drug Targets 16:592–609.
  • Cheung N, Chan LC, Thompson A, et al. (2007). Protein arginine-methyltransferase-dependent oncogenesis. Nat Cell Biol 9:1208–15.
  • Croft A, Campos J, Jansen K, et al. (2018). Pathologically distinct fibroblast subsets drive inflammation and tissue damage in arthritis. BioRxiv, 374330.
  • Feng Y, Maity R, Whitelegge JP, et al. (2013). Mammalian protein arginine methyltransferase 7 (PRMT7) specifically targets RXR sites in lysine- and arginine-rich regions. J Biol Chem 288:37010–25.
  • Giordano G, Pancione M, Olivieri N, et al, (2017). Nano albumin bound-paclitaxel in pancreatic cancer: current evidences and future directions. World J Gastroenterol 23:5875–86.
  • Goulet I, Gauvin G, Boisvenue S, Côté J. (2007). Alternative splicing yields protein arginine methyltransferase 1 isoforms with distinct activity, substrate specificity, and subcellular localization. J Biol Chem 282:33009–21.
  • Heinke R, Trojer P, Sippl W, et al. (2008). Virtual screening and biological characterization of novel histone arginine methyltransferase PRMT1 Inhibitors. Chem Med Chem 4:69–77.
  • IARC. (2018). Latest Global Cancer Data. Press Release N° 263. World Health Organization, (September), 13–15. Available at: http://gco.iarc.fr/.
  • Jang HY, Kim KW, Kwon JH, et al. (2017). N-butyl-2 cyanoacrylate (NBCA) embolus in the graft portal vein after portosystemic collateral embolization in liver transplantation recipient: What is the clinical significance? Acta Radiol 58:1326–33.
  • Kong D, Wang W, Du G, et al. (2018). Liver retraction using n-Butyl-2-Cyanoacrylate (NBCA) glue during laparoscopic splenectomy and azygoportal disconnection in cirrhotic patients. BioMed Res Int 2018:1–7.
  • Lu C, Wang X, Wu G, et al. (2014). An injectable and biodegradable hydrogel based on poly(α,β- aspartic acid) derivatives for localized drug delivery. J Biomed Mater Res 102:628–38.
  • Madan E, Pelham CJ, Nagane M, et al. (2019). Flower isoforms promote competitive growth in cancer. Nature 572:260–4.
  • Mathioudaki K, Papadokostopoulou A, Scorilas A, et al. (2008). The PRMT1 gene expression pattern in colon cancer. Br J Cancer 99:2094–9.
  • Matsuda T, Yamashita K, Hasegawa H, et al. (2018). Recent updates in the surgical treatment of colorectal cancer. Ann Gastroenterol Surg 2:129–36.
  • Raza A, Hayat U, Rasheed T, et al. (2018). Redox-responsive nano-carriers as tumor-targeted drug delivery systems. Eur J Med Chem 157:705–15.
  • Sugawara S, Arai Y, Sone M, et al. (2019). Phase II trial of transarterial embolization using an n-Butyl-2-Cyanoacrylate/Lipiodol Mixture (JIVROSG-0802). Cardiovasc Intervent Radiol 42:534–41.
  • Warembourg M, Leroy D. (2000). Microwave pretreatment of sections to improve the immunocytochemical detection of progesterone receptors in the guinea pig hypothalamus. J Neurosci Methods 104:27–34.
  • Werner ME, Cummings ND, Sethi M, et al. (2013). Preclinical evaluation of genexol-pm, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 86:463–8.
  • Wu Y, Wang L, Zhang K, et al. (2017). N -Butyl-2-cyanoacrylate-based injectable and in situ -forming implants for efficient intratumoral chemotherapy. Drug Delivery 24:729–36.
  • Yamashita S, Okada Y. (2005). Application of heat-induced antigen retrieval to aldehyde-fixed fresh frozen sections. J Histochem Cytochem 53:1421–32.
  • Yang Y, Bedford MT. (2013). Protein arginine methyltransferases and cancer. Nat Rev Cancer 13:37–50.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.